Send feedback

CYLD p.Arg53His

c.158G>A · rs375455772 · VCV2885534

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely benign
0.3215 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00933%, afr)
Missense predictors
0/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
frontotemporal dementia and/or amyotrophic lateral sclerosis 8

Computational evidence

Protein change
AlphaMissense0.3215likely benign
REVEL0.575indeterminate
SaProtLLR -6.42tolerated
⇒ AlphaMissense and SaProt both call this tolerated; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 2.4, phastCons 1
Regional constrainto/e 0.86unconstrained · MANE · 435 bp · p 0.072 · regional, not allelic
Overall
CADD25.8PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean tolerated — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00933% African / African-American · 7/75,024 alleles
Filtering AF 0.00437% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00308%
Overall 0.00192% 31/1,614,110 alleles · very rare
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0096% 10,418
African / African-Americangrpmax 0.00933% 10,718
Admixed American 0.00833% 12,002
South Asian 0.0022% 45,540
European (non-Finnish) 0.000932% 107,274

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
CYLD
Protein
p.Arg53His
Coding
c.158G>A
MANE Select
NM_001378743
dbSNP
rs375455772
Type
single nucleotide variant
Location
chr16:50749856 (GRCh38)
Gene constraint
LOEUF 0.325 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Structure
AlphaFold pLDDT 75.06 · 6 PDB
Full CYLD gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

frontotemporal dementia and/or amyotrophic lateral sclerosis 8 — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Frontotemporal dementia with motor neuron disease (Orphanet):

Inheritance
Autosomal dominant
Onset
Adult

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/cyld-p-arg53his (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown